Dr. Belalcazar-Portacio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 St Lukes Dr
Montgomery, AL 36117Phone+1 334-273-8877Fax+1 334-273-9733
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2017
University of TennesseeResidency, Internal Medicine, 2011 - 2014
Institute of Health Sciences Medellin Faculty of MedicineClass of 2007
Certifications & Licensure
AL State Medical License 2019 - 2024
ME State Medical License 2017 - 2020
GA State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsIn-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy.Walid L. Shaib, Katerina Mary Zakka, Farhan N. Hoodbhoy, Astrid Belalcazar, Sungjin Kim
Journal of Geriatric Oncology. 2020-05-01 - 56 citationsInhibition of NF-κB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer.Balney Rajitha, Astrid Belalcazar, Ganji Purnachandra Nagaraju, Walid L. Shaib, James P. Snyder
Cancer Letters. 2016-04-10 - 17 citationsInhibiting heat shock protein 90 and the ubiquitin-proteasome pathway impairs metabolic homeostasis and leads to cell death in human pancreatic cancer cells.Astrid Belalcazar, Walid L. Shaib, Matthew R. Farren, Chao Zhang, Zhengjia Chen
Cancer. 2017-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
